The European Commission (EC) has approved Blincyto (blinatumomab) monotherapy as part of consolidation therapy for the treatment of adults with newly-diagnosed Philadelphia chromosome-negative ...

The EC's decision was based on results from a Phase III trial of Blincyto with multiphase consolidation chemotherapy.

The EC's decision was based on results from a Phase III trial of Blincyto with multiphase consolidation chemotherapy.

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

12, 2024 — Scientists have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...

Hammer Down Cancer game featured player-worn jerseys auctioned off for cancer research, and coaches' shoes will be auctioned ...

Braden Smith had a big night statistically Friday against Michigan. But it pales in comparison to the dollar figure his ...

Because of this, symptoms of acute leukemia occur suddenly and tend to be far more severe than chronic leukemias. The two main types of acute leukemia are acute lymphocytic leukemia (ALL) and acute ...

"It’s an honor and privilege for me to wear Alexa’s shoes," says Painter. Alexa Wood, 13, was diagnosed with leukemia hours ...

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, ...